最新消息: USBMI致力于为网友们分享Windows、安卓、IOS等主流手机系统相关的资讯以及评测、同时提供相关教程、应用、软件下载等服务。

Semi-synthetic glycosaminoglycans containing alpha

IT圈 admin 25浏览 0评论

2024年3月19日发(作者:步飞宇)

专利内容由知识产权出版社提供

专利名称:Semi-synthetic glycosaminoglycans

containing alpha-L-galacturonic acid

substituted with nucleophilic radicals in

position 3

发明人:Piani, Silvano,Marchi, Egidio,Tamagnone,

Gianfranco,Ungarelli, Fabrizio

申请号:EP93103847.5

申请日:19930310

公开号:EP0565862A2

公开日:19931020

摘要:The synthesis of new semi-synthetic glycosaminoglycans is described in which

one of the saccharide units characteristic of glycosaminoglycans with heparin or heparan

structure, more specifically that of α-L-iduronic-2-O-sulfate acid, has undergone a

structural modification, entirely or in part, with transformation into α-L-galacturonic acid

substituted with nucleophilic radicals in position 3. These new semi-synthetic

glycosaminoglycans of general formula IV have good pharmaceutical properties in that

they may also be absorbed orally and have good anti-thrombotic activity accompanied by

low risk of hemorrhage and reduced anti-coagulating activity.

申请人:ALFA WASSERMANN S.p.A.

地址:Contrada Sant'Emidio I-65020 Alanno Scalo (Pescara) IT

国籍:IT

代理机构:Kraus, Walter, Dr.

更多信息请下载全文后查看

2024年3月19日发(作者:步飞宇)

专利内容由知识产权出版社提供

专利名称:Semi-synthetic glycosaminoglycans

containing alpha-L-galacturonic acid

substituted with nucleophilic radicals in

position 3

发明人:Piani, Silvano,Marchi, Egidio,Tamagnone,

Gianfranco,Ungarelli, Fabrizio

申请号:EP93103847.5

申请日:19930310

公开号:EP0565862A2

公开日:19931020

摘要:The synthesis of new semi-synthetic glycosaminoglycans is described in which

one of the saccharide units characteristic of glycosaminoglycans with heparin or heparan

structure, more specifically that of α-L-iduronic-2-O-sulfate acid, has undergone a

structural modification, entirely or in part, with transformation into α-L-galacturonic acid

substituted with nucleophilic radicals in position 3. These new semi-synthetic

glycosaminoglycans of general formula IV have good pharmaceutical properties in that

they may also be absorbed orally and have good anti-thrombotic activity accompanied by

low risk of hemorrhage and reduced anti-coagulating activity.

申请人:ALFA WASSERMANN S.p.A.

地址:Contrada Sant'Emidio I-65020 Alanno Scalo (Pescara) IT

国籍:IT

代理机构:Kraus, Walter, Dr.

更多信息请下载全文后查看

发布评论

评论列表 (0)

  1. 暂无评论